Cargando…

Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala

INTRODUCTION: Viral suppression prevents HIV transmission and disease progression, but socio-economic and clinical factors can hinder the goal of suppression. We evaluated factors associated with viral non suppression (VNS) and persistent viremia (PV) in people living with HIV (PLHIV) receiving anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortíz, Dean W., Roberts-Sano, Olivia, Marroquin, Hugo E., Larson, Lindsey, Franco, Katherine B., Spec, Andrej, Melendez, Johanna R., Pinzón, Rodolfo, Samayoa, Ana J., Mejia-Chew, Carlos, O´Halloran, Jane A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554948/
https://www.ncbi.nlm.nih.gov/pubmed/34706742
http://dx.doi.org/10.1186/s12981-021-00400-9
_version_ 1784591885722976256
author Ortíz, Dean W.
Roberts-Sano, Olivia
Marroquin, Hugo E.
Larson, Lindsey
Franco, Katherine B.
Spec, Andrej
Melendez, Johanna R.
Pinzón, Rodolfo
Samayoa, Ana J.
Mejia-Chew, Carlos
O´Halloran, Jane A.
author_facet Ortíz, Dean W.
Roberts-Sano, Olivia
Marroquin, Hugo E.
Larson, Lindsey
Franco, Katherine B.
Spec, Andrej
Melendez, Johanna R.
Pinzón, Rodolfo
Samayoa, Ana J.
Mejia-Chew, Carlos
O´Halloran, Jane A.
author_sort Ortíz, Dean W.
collection PubMed
description INTRODUCTION: Viral suppression prevents HIV transmission and disease progression, but socio-economic and clinical factors can hinder the goal of suppression. We evaluated factors associated with viral non suppression (VNS) and persistent viremia (PV) in people living with HIV (PLHIV) receiving antiretroviral therapy (ART) in Guatemala. METHODS: We conducted a cross sectional analysis using data from an ongoing cohort of PLHIV attending the largest HIV clinic in Guatemala. Univariable and multivariable analyses were conducted between PLHIV with viral suppression and detectable viremia. VNS was defined as most recent HIV RNA ≥ 200 copies/ml and PV as two consecutive HIV RNA ≥ 200 copies/ml. RESULTS: Of 664 participants, 13.3% had VNS and 7.1% had PV. In univariable analysis disaggregated by gender, low income, poor education, perceived difficulty attending healthcare, and alcohol use were associated with VNS in men while low CD4 at diagnosis, multiple prior ART regimens and treatment interruptions were significant in both genders. Multiple prior ART regimens (adjusted Odds Ratio (aOR) 2.82, [95% confidence interval (CI) 1.59, 4.99], p < 0.01), treatment interruptions (aOR 4.51, [95% CI 2.13, 9.58], p < 0.01), excessive alcohol consumption (aOR 2.56, [95% CI 1.18, 5.54], p < 0.05) perceived difficulty attending healthcare (aOR 2.07, [ 95% CI 1.25, 3.42], p < 0.01) and low CD4 at diagnosis (aOR 2.34, 95% [CI 1.30, 4.20], p < 0.01) were independently associated with VNS on multivariable regression. CONCLUSIONS: We conclude that socio-economic and clinical factors influence viral suppression in our cohort and vary between men and women. Gender specific approaches are necessary to achieve the 90% suppression goal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-021-00400-9.
format Online
Article
Text
id pubmed-8554948
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85549482021-10-29 Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala Ortíz, Dean W. Roberts-Sano, Olivia Marroquin, Hugo E. Larson, Lindsey Franco, Katherine B. Spec, Andrej Melendez, Johanna R. Pinzón, Rodolfo Samayoa, Ana J. Mejia-Chew, Carlos O´Halloran, Jane A. AIDS Res Ther Research INTRODUCTION: Viral suppression prevents HIV transmission and disease progression, but socio-economic and clinical factors can hinder the goal of suppression. We evaluated factors associated with viral non suppression (VNS) and persistent viremia (PV) in people living with HIV (PLHIV) receiving antiretroviral therapy (ART) in Guatemala. METHODS: We conducted a cross sectional analysis using data from an ongoing cohort of PLHIV attending the largest HIV clinic in Guatemala. Univariable and multivariable analyses were conducted between PLHIV with viral suppression and detectable viremia. VNS was defined as most recent HIV RNA ≥ 200 copies/ml and PV as two consecutive HIV RNA ≥ 200 copies/ml. RESULTS: Of 664 participants, 13.3% had VNS and 7.1% had PV. In univariable analysis disaggregated by gender, low income, poor education, perceived difficulty attending healthcare, and alcohol use were associated with VNS in men while low CD4 at diagnosis, multiple prior ART regimens and treatment interruptions were significant in both genders. Multiple prior ART regimens (adjusted Odds Ratio (aOR) 2.82, [95% confidence interval (CI) 1.59, 4.99], p < 0.01), treatment interruptions (aOR 4.51, [95% CI 2.13, 9.58], p < 0.01), excessive alcohol consumption (aOR 2.56, [95% CI 1.18, 5.54], p < 0.05) perceived difficulty attending healthcare (aOR 2.07, [ 95% CI 1.25, 3.42], p < 0.01) and low CD4 at diagnosis (aOR 2.34, 95% [CI 1.30, 4.20], p < 0.01) were independently associated with VNS on multivariable regression. CONCLUSIONS: We conclude that socio-economic and clinical factors influence viral suppression in our cohort and vary between men and women. Gender specific approaches are necessary to achieve the 90% suppression goal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-021-00400-9. BioMed Central 2021-10-27 /pmc/articles/PMC8554948/ /pubmed/34706742 http://dx.doi.org/10.1186/s12981-021-00400-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ortíz, Dean W.
Roberts-Sano, Olivia
Marroquin, Hugo E.
Larson, Lindsey
Franco, Katherine B.
Spec, Andrej
Melendez, Johanna R.
Pinzón, Rodolfo
Samayoa, Ana J.
Mejia-Chew, Carlos
O´Halloran, Jane A.
Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
title Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
title_full Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
title_fullStr Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
title_full_unstemmed Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
title_short Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
title_sort factors associated with viremia in people living with hiv on antiretroviral therapy in guatemala
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554948/
https://www.ncbi.nlm.nih.gov/pubmed/34706742
http://dx.doi.org/10.1186/s12981-021-00400-9
work_keys_str_mv AT ortizdeanw factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT robertssanoolivia factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT marroquinhugoe factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT larsonlindsey factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT francokatherineb factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT specandrej factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT melendezjohannar factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT pinzonrodolfo factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT samayoaanaj factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT mejiachewcarlos factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala
AT ohalloranjanea factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala